Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base ...

For teens entering high school—an anxious time for many—inclusive environments benefit not only those identifying as LGBTQ ...

Strengthening collaboration to drive innovation across AI, biomedical research, and translational medicine PUNE, ...

Developing effective cardiovascular therapies requires robust, translational preclinical data that can reliably predict ...

New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 new biomarkers developed with support from ...

Patients with RA who use abatacept mount little humoral or cell-mediated responses to the recombinant zoster vaccine, with more injection-site reactions but similar RA flare rates compared with ...

The new €3.2M (US$3.7M) research lab will investigate immunogenic cell death mechanisms in lung cancer to improve how existing therapies trigger immune response.

NOTCH3-ECD is a specific IPAH biomarker, Cloud-Clone’s SEL147Hu ELISA Kit powers this breakthrough HUSTON, TX, UNITED STATES, March 17, 2026 /EINPresswire.com/ — A groundbreaking study published in ...

Not all cancer mutations are equal. A Nature Genetics study led by Dr. Derya Deniz Özdemir (Koç University) shows that even small differences in a ...

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of the NULISAseq Neuro 220 Panel with ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...

AI automation, and more skilled staff are needed to ensure cancer patients can access potentially life-saving CAR T therapies.